Related Experiment Video
Updated: Dec 31, 2025

06:45
Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems
Published on: May 2, 2025
790
Electrospun Bioresorbable Membrane Eluting Chlorhexidine for Dental Implants
Pierre Pouponneau1, Ophélie Perrey1, Céline Brunon2
1Statice, 25000 Besançon, France.
Polymers
|January 8, 2020
Summary
A novel electrospun membrane incorporating chlorhexidine diacetate (CHX) was developed to prevent dental implant biofilm formation. This antimicrobial membrane demonstrated sustained drug release and effective bacterial inhibition, paving the way for improved implant integration.
Area of Science:
- Biomaterials Science
- Dental Implantology
- Drug Delivery Systems
Background:
- Dental implant-associated infections and pathogenic biofilm formation pose significant clinical challenges.
- Current strategies for preventing peri-implantitis often involve systemic or local antimicrobial administration with limitations.
- Developing localized, sustained antimicrobial delivery systems is crucial for enhancing dental implant success rates.
Purpose of the Study:
- To engineer an antimicrobial drug-releasing electrospun membrane for preventing pathogenic biofilm development around dental implants.
- To optimize membrane formulation using poly(l-lactic-co-gycolic acid) (PLGA) and poly(l-lactic acid-co-ɛ-caprolactone) (PLC) copolymers loaded with chlorhexidine diacetate (CHX).
- To evaluate the membrane's physicochemical properties, drug release kinetics, antimicrobial efficacy, and biocompatibility in a preclinical setting.
Main Methods:
- Electrospinning of PLGA/PLC copolymer blends with chlorhexidine diacetate (CHX) complexed with β-cyclodextrin (CD).
- Tuning of membrane properties (residual solvent, mechanical strength, drug release) by varying copolymer ratios and CHX loading.
- Sterilization via γ-irradiation and characterization of fiber morphology (diameter 600 nm–3 µm).
- In vitro drug release studies and determination of bacterial inhibitory concentration.
- Subcutaneous implantation in a rat model to assess biocompatibility and cell penetration.
Main Results:
- Membrane formulation optimized using a 60% PLGA / 40% PLC blend with 4% CHX-CD achieved desirable mechanical properties (50% breaking strain) for handling.
- Sustained in vitro release of CHX over 10 days, reaching the bacterial inhibitory concentration (80 µg·mL⁻¹) within eight days.
- Sterilization by γ-irradiation did not significantly alter membrane properties.
- Subcutaneous implantation showed low cell penetration, indicating good initial biocompatibility.
Conclusions:
- The developed PLGA/PLC/CHX-CD electrospun membrane effectively delivers antimicrobial agents to prevent dental implant biofilm.
- The membrane exhibits suitable mechanical properties and sustained drug release, offering a promising localized antimicrobial strategy.
- Further optimization of membrane porosity is recommended to enhance cell penetration and promote tissue remodeling for improved long-term integration.

